All lobbying filings

THE MCMANUS GROUP

Lobbying for FULCRUM THERAPEUTICS · Rare disease biopharma company

Filing Registration

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Jan 17, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Massachusetts

Official filing document

Lobbying activity 1

Health Issues

Sickle Cell disease education Orphan Drug Tax Credit Priority review vouchers

Affiliated organizations 1

Section 6 of the LD-2: organizations that contribute to this lobbying or take an active part in directing it. On a trade association's filing, this is where its backers appear.

FULCRUM THERAPEUTICS

Cambridge, Massachusetts

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.